When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street analysts for guidance. And when it comes to the two biotech stocks he highlights that are approaching significant catalysts, the analysts see impressive upside potential from current levels. For these two biotech stocks – both of which boast “Strong Buy” consensus ratings – CLICK HERE.
Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
- by RobH